Minims Tropicamide Bausch + Lomb (Tropicamide)

Tropicamide works by competitively blocking muscarinic acetylcholine receptors in the iris sphincter muscle. By preventing parasympathetic stimulation, the sphincter relaxes, leading to pupil dilation and loss of the eye’s focusing ability, which are useful for diagnostic and therapeutic purposes.

The dosing regimen is determined by the prescribing eye‑care professional. Typically, one to two drops are instilled in the affected eye(s) as directed, with the interval and any repeat dosing specified by the clinician based on the required degree of dilation.

Safety data for tropicamide during pregnancy and lactation are limited, and it is generally classified as a category C or unknown drug. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, after consultation with a qualified healthcare provider.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Tropicamide has a relatively rapid onset and short duration of action compared with agents such as phenylephrine or cyclopentolate. It provides sufficient pupil dilation for routine examinations while minimizing prolonged visual disturbance, making it a preferred choice for many diagnostic settings.

Store at room temperature, ideally below 25 °C, in the original sealed container. Protect the bottle from direct light and moisture, and keep it out of reach of children. Do not freeze the solution.

The product is supplied as a sterile ophthalmic solution. The patient or clinician instills the prescribed number of drops into the conjunctival sac of the target eye(s) using the provided dropper, avoiding contact with the eye or surrounding tissues, and follows any post‑administration instructions.

Although uncommon, serious adverse events include acute angle‑closure glaucoma, severe allergic reactions such as anaphylaxis, and prolonged mydriasis leading to significant photophobia. Patients should seek immediate medical attention if they experience severe eye pain, sudden vision loss, or systemic allergic symptoms.

Contraindications include individuals with known hypersensitivity to tropicamide or any formulation component, patients with narrow‑angle or uncontrolled glaucoma, and anyone in whom pupil dilation could compromise ocular health. Use should be avoided unless a qualified eye‑care professional determines it is safe.